Description

TIDES: Oligonucleotide and Peptide Therapeutics is an event that consists of two conference EuroTides and EuroPeptides, covering clinical, manufacturing and R&D developments for RNAi, miRNA, Antisense, Aptamers and Peptides.

Topics

GalNAc-conjugated siRNAs as a new paradigm in oligonucleotide therapeutics
Critical feedback on the current status and future developments of antisense technology
Strategies to overcome the delivery and manufacturing challenges for mRNA therapeutics
Novel strategies to improve the delivery of oligonucleotides to the liver and beyond
The future of oligonucleotides and the potential of emerging new silencing technologies
Best practises for the manufacture, analytical and process considerations for oligonucleotide therapeutics
Formulation strategies and the most successful technologies for sustained release of your peptide product
Pre-clinical and clinical programmes with case studies insights
Processes to optimise peptide synthesis and large scale peptide manufacturing
Developments in non-invasive delivery methods including recent developments in orally bioavailable peptides
Advances in analytical strategies and tools for characterising impurities and understanding metabolism of peptide drug candidates
The application of microwave synthesisers to scale up peptide production
Methodologies to increase the half-life, stability and retention rates of peptide products